The malignant and local invasion of M2 macrophages in the tumor indicates a poor prognosis for patients with triple-negative breast cancer (TNBC), which can be ameliorated by SMS2 inhibition or knockout in TNBC mouse models [113]. The gene discussed is SGMS2; the disease is neoplasm.